No Data
No Data
Ziyuan Yuan (08223) announced annual results. Profit attributable to shareholders of 145.63 million yuan decreased by 7.9% year-on-year
Ziyuanyuan (08223) announced the results for the year ended December 31, 2023. The group obtained total revenue, people...
ZYY: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Ziyuanyuan (08223) plans to discount approximately 19.23% and issue 30 million subscription shares to raise about HK$43.5 million net
According to the Zhitong Finance App, Ziyuan (08223) announced that on December 29, 2023, the company plans to issue 15 million subscription shares to Yu Jianping and Zheng Zhihong respectively. The subscription price for each subscribed share is HK$1.47, a discount of about 19.23% from the closing price of HK$1.82 per share. Net funding of approximately HK$43.5 million is intended to be used for general working capital to develop the Group's financial leasing business and medical device and consumables trading business. On the same day, that is, the final end date of the placement agreement, the prerequisites for the placement agreement have not been met, and the proposed transactions under the placement agreement have expired and been terminated
Zi Yuanyuan (08223) plans to discount approximately 13.28%, place up to 40 million shares, place up to 40 million shares, net raise about HK$42.7 million
Zi Yuanyuan (08223) issued an announcement. On December 12, 2023, the company signed a placement agreement with the placement agent...
Zi Yuanyuan (08223.HK) plans to further develop medical device and consumables trading business
Gelonghui November 24 | Zi Yuanyuan (08223.HK) announced that on November 24, 2023, the company (“buyer”) signed a memorandum of understanding with He Chao, Shenzhen Yunrui Investment Limited Partnership (Limited Partnership) and Shenzhen Borui Cloud Investment Partnership (“Seller”). According to the MOU, the buyer intended to buy and the seller intended to sell shares of Shenzhen Chuangda Yunrui Intelligent Technology Co., Ltd. (“Target Company”) and the buyer intended to inject capital into the target company. After the shares to be sold and capital injections are completed, the Group intends to own 51% of the target company's shares. The target company is a limited company established in China
ZYY: THIRD QUARTERLY REPORT 2023
No Data